Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Feb 2, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Travere Therapeutics, Inc.
20.24K
$8.71
-$41,495.10
+33.46%
80.72K
+1
Jan 31 - Feb 1
Travere Therapeutics, Inc.
-2.06K
$8.96
-$18,475.52
-3.30%
60.48K
+1
Jan 23
Travere Therapeutics, Inc.
1.49K
$14.71
-$26,698.65
+2.49%
61.17K
+1
Aug 31 - Sep 5
Travere Therapeutics, Inc.
-825.00
$16.59
-$13,686.75
-1.37%
59.21K
+1
May 10
Travere Therapeutics, Inc.
17.66K
$22.25
-$57,627.50
+41.67%
60.04K
+1
Jan 31 - Feb 1
Scheduled
Travere Therapeutics, Inc.
-2.06K
$21.50
-$44,333.00
-4.64%
42.38K
+1
Jan 24
Scheduled
Travere Therapeutics, Inc.
-1.56K
$21.71
-$33,940.25
-3.46%
43.67K
+1
May 11
Scheduled
Travere Therapeutics, Inc.
8.71K
$27.40
-$30,825.00
+23.86%
45.23K
+1
Jan 31
Scheduled
Travere Therapeutics, Inc.
-1.88K
$24.98
-$46,837.50
-4.88%
36.52K
+1
Jan 24
Scheduled
Travere Therapeutics, Inc.
2.5K
$27.40
-$68,500.00
+6.96%
38.4K
+1
Jan 10 - Jan 11
Scheduled
Travere Therapeutics, Inc.
3.09K
$17.12
-$24,085.45
+9.48%
35.73K
+1
Aug 13 - Aug 17
Travere Therapeutics, Inc.
-3.13K
$19.30
-$60,312.34
-8.97%
31.71K
+1
May 11 - May 12
Scheduled
Travere Therapeutics, Inc.
-2.50K
$28.01
-$70,025.00
-6.70%
34.83K
+1
Feb 17 - Feb 18
Scheduled
Travere Therapeutics, Inc.
-4.50K
$31.50
-$141,727.50
-10.76%
37.33K
+1
Feb 5 - Feb 8
Scheduled
Travere Therapeutics, Inc.
4.5K
—
—
+12.05%
41.83K
+1
Feb 3
Travere Therapeutics, Inc.
-3.63K
$28.91
-$104,798.75
-8.85%
37.33K
+1
Feb 3
Scheduled
Travere Therapeutics, Inc.
1.38K
$30.75
-$111,468.75
+1.08%
129K
+1
Jan 31 - Feb 2
Scheduled
Travere Therapeutics, Inc.
15K
—
—
+61.02%
39.58K
+1
Jan 21
Travere Therapeutics, Inc.
-2.50K
$23.96
-$59,900.00
-9.40%
24.09K
+1
Nov 16
Scheduled
Retrophin, Inc.
2.5K
$23.62
-$59,056.00
+10.38%
26.59K
+1
Nov 11 - Nov 13
Scheduled
Retrophin, Inc.
-1.50K
$18.48
-$27,720.00
-5.86%
24.09K
+1
Sep 23
Scheduled
Retrophin, Inc.
1.5K
$18.59
-$27,885.00
+6.23%
25.59K
+1
Sep 18 - Sep 22
Scheduled
Retrophin, Inc.
-2.15K
$16.28
-$35,039.00
-8.39%
23.49K
+1
May 11 - May 12
Scheduled
Retrophin, Inc.
-3.25K
$14.87
-$48,327.50
-11.25%
25.65K
+1
Mar 10
Scheduled
Retrophin, Inc.
3.25K
—
—
+12.67%
28.9K
+1
Mar 5
Retrophin, Inc.
-2.50K
$16.64
-$41,587.50
-8.88%
25.65K
+1
Feb 14 - Feb 18
Scheduled
Retrophin, Inc.
9K
—
—
+49.49%
27.18K
+1
Jan 31
Retrophin, Inc.
-1.63K
$17.77
-$28,876.26
-8.20%
18.18K
+1
May 14 - May 15
Scheduled
Retrophin, Inc.
6K
—
—
+43.45%
19.81K
+1
May 9
Retrophin, Inc.
-2.50K
$21.48
-$53,700.00
-15.33%
13.81K
+1
Feb 15 - Feb 19
Scheduled
Retrophin, Inc.
-1.99K
$21.44
-$42,558.34
-11.03%
16.01K
+1
Feb 11 - Feb 12
Scheduled
Retrophin, Inc.
-5.00K
$24.03
-$120,129.55
-21.75%
17.99K
+1
Nov 14 - Nov 15
Scheduled
Retrophin, Inc.
5K
—
—
+27.79%
22.99K
+1
Nov 9
Retrophin, Inc.
6.5K
—
—
+58.26%
17.66K
+1
May 10
Retrophin, Inc.
-1.03K
$21.50
-$22,232.03
-8.48%
11.16K
+1
Feb 14
Retrophin, Inc.
1.99K
—
—
+19.45%
12.19K
+1
Feb 8
Retrophin, Inc.
10K
—
—
∞
10K
+1
Feb 13
Retrophin, Inc.
0
—
—
—
0
+1

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.